Compugen Ltd. (NASDAQ:
CGEN) today announced that the Company will host a conference call
at 10:00 AM EDT on Wednesday, August 6, 2014 to review the second
quarter 2014 results. The quarterly results will be released on the
Company’s website (www.cgen.com),
prior to the conference call. A previous
release stating August 5 as the date for the call was in error.
To access the conference call, please dial 1-888-281-1167 from the US,
or + 972-3-918-0610 internationally. The call will also be available via
live webcast located at the following link.
A replay of the conference call will be available approximately two
hours after the completion of the live conference call. To access the
replay, please dial 1-877-456-0009 from the US or +972-3-925-5925
internationally. The replay will be available through August 8, 2014.
About Compugen
Compugen is a leading drug discovery company focused on therapeutic
proteins and monoclonal antibodies to address important unmet needs in
the fields of immunology and oncology. The Company utilizes a broad and
continuously growing integrated infrastructure of proprietary scientific
understandings and predictive platforms, algorithms, machine learning
systems and other computational biology capabilities for the in
silico (by computer) prediction and selection of product candidates,
which are then advanced in its Pipeline Program. The Company's business
model includes collaborations covering the further development and
commercialization of product candidates at various stages from its
Pipeline Program and various forms of research and discovery agreements,
in both cases providing Compugen with potential milestone payments and
royalties on product sales or other forms of revenue sharing. Compugen’s
wholly-owned U.S. subsidiary located in South San Francisco is
developing oncology and immunology monoclonal antibody therapeutic
candidates against its drug targets. For additional information, please
visit Compugen's corporate website at www.cgen.com.
Copyright Business Wire 2014